Controlled release hydrocodone

US9060940B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9060940-B2
Application numberUS-201414210565-A
CountryUS
Kind codeB2
Filing dateMar 14, 2014
Priority dateOct 30, 2000
Publication dateJun 23, 2015
Grant dateJun 23, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

First claim

Opening claim text (preview).

We claim: 1. A method of providing effective pain relief to a patient in need thereof comprising: obtaining a serum profile of an opioid in the patient, having a plasma level with a C 24 /C max ratio of about 0.55 to about 1.0, by administering orally on a once-a-day basis a controlled release formulation of the opioid to the patient, wherein the controlled release formulation releases an analgesically effective amount of the opioid at an effective rate to provide said serum pr…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9060940B2 cover?
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
Who is the assignee on this patent?
Purdue Pharma Lp
What technology area does this patent fall under?
Primary CPC classification A61K31/485. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).